{
    "2021-11-22": [
        [
            {
                "time": "",
                "original_text": "万泰生物：公司产品尚处于临床进展过程中",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "产品",
                        "临床进展"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "万泰生物现1笔大宗交易 共成交253.00万元",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：合作研发的鼻喷新冠疫苗近日获得了南非药监部门签发的Ⅲ期临床试验批件",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "鼻喷新冠疫苗",
                        "南非",
                        "Ⅲ期临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：公司在菲律宾的鼻喷新冠疫苗三期临床尚未开始",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "菲律宾",
                        "鼻喷新冠疫苗",
                        "三期临床"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物今日大宗交易成交1万股，成交价253.0元溢价2.02%",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "大宗交易",
                        "溢价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：总工程师李益民拟减持不超过15万股 拟减持股份数量",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "总工程师",
                        "减持",
                        "股份数量"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "“豪赌”HPV，万泰生物想做新一代疫苗之王？",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "HPV",
                        "疫苗",
                        "豪赌"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}